NLRX1 and infectious otitis media: In DSS/AOM and APCmin/+ murine models of colorectal cancer (CRC), NLRX1 was shown to supress the development of CRC, as deletion of NLRX1 resulted in increased susceptibility, mortality and tumor burden [14,66].